Clinical-grade services ACGT operates CLIA accredited facilities offering standard research level, GLP, and cGMP compliant clinical grade services, indicating a potential upsell to regulated environments for client drug development and diagnostic projects.

Integrated sequencing capabilities With high throughput Sanger sequencing, NGS and genomics, genotyping, qPCR, and cDNA library construction, ACGT presents a broad portfolio suitable for expanding collaborations in translational research, assay development, and biomarker discovery.

Regional footprint Two locations in the Chicago north suburbs and the Washington, D.C. metro area position ACGT to service mid-Atlantic and Midwestern biopharma, academia, and public health agencies, signaling territory-focused sales approaches.

Regulatory readiness CAP accreditation and GLP/cGMP compliance suggest readiness for quality-focused clients and regulated study outsourcing, offering cross-sell opportunities to firms needing audit-ready sequencing and analytics support.

Growth-friendly scale Revenue in the multi-tens of millions with 51-200 employees implies operational capacity for larger project engagements, strategic partnerships, and expanded service lines with minimal new hires through partner-led delivery.